Standard InChI: InChI=1S/C21H26N2O4S2/c1-5-27-20(24)18-17-12(2)7-6-8-16(17)29-19(18)23-21(28)22-13-9-10-14(25-3)15(11-13)26-4/h9-12H,5-8H2,1-4H3,(H2,22,23,28)
1.Xue D,Chen W,Neamati N. (2020) Discovery, structure-activity relationship study and biological evaluation of 2-thioureidothiophene-3-carboxylates as a novel class of C-X-C chemokine receptor 2 (CXCR2) antagonists., 204 [PMID:32829163][10.1016/j.ejmech.2020.112387]
2.Cutshall, N S NS, Ursino, R R, Kucera, K A KA, Latham, J J and Ihle, N C NC. 2001-07-23 Nicotinamide N-oxides as CXCR2 antagonists. [PMID:11459668]
3.Cutshall, Neil S NS, Kucera, Kristin A KA, Ursino, Rocky R, Latham, John J and Ihle, Nathan C NC. 2002-06-03 Nicotinanilides as inhibitors of neutrophil chemotaxis. [PMID:12031332]
4.Widdowson, Katherine L KL and 14 more authors. 2004-03-11 Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptor. [PMID:14998320]
5.Karlström, Sofia S and 20 more authors. 2013-04-25 Substituted 7-amino-5-thio-thiazolo[4,5-d]pyrimidines as potent and selective antagonists of the fractalkine receptor (CX3CR1). [PMID:23516963]
6.Bachelerie, Francoise F and 22 more authors. 2014 International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. [PMID:24218476]
7.Austin, Rupert P RP and 14 more authors. 2015-04-01 Discovery and evaluation of a novel monocyclic series of CXCR2 antagonists. [PMID:25708618]
8.Maeda, Dean Y and 8 more authors. 2015-06-01 Boronic acid-containing CXCR1/2 antagonists: Optimization of metabolic stability, in vivo evaluation, and a proposed receptor binding model. [PMID:25933594]
9.Miller, Bruce E and 8 more authors. 2015-06-20 The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756)--a selective CXCR2 antagonist --in healthy adult subjects. [PMID:26092545]
10.Schuler, Aaron D and 8 more authors. 2015-09-15 Boronic acid-containing aminopyridine- and aminopyrimidinecarboxamide CXCR1/2 antagonists: Optimization of aqueous solubility and oral bioavailability. [PMID:26248802]
11.Xu, Heng H and 19 more authors. 2016-04-14 Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders. [PMID:27096048]
12.Gege, Christian and 15 more authors. 2018-05-15 Identification and biological evaluation of thiazole-based inverse agonists of RORγt. [PMID:29631962]